United States Steel & Carnegie Pension Fund’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$62.6M Hold
813,541
2.86% 8
2017
Q2
$60.8M Sell
813,541
-295,454
-27% -$20.9M 2.54% 10
2017
Q1
$73.8M Sell
1,108,995
-150,771
-12% -$10M 2.31% 13
2016
Q4
$82.2M Hold
1,259,766
2.44% 10
2016
Q3
$89.1M Sell
1,259,766
-282,481
-18% -$20.6M 2.63% 7
2016
Q2
$114M Hold
1,542,247
2.63% 5
2016
Q1
$100M Hold
1,542,247
2.32% 11
2015
Q4
$119M Hold
1,542,247
2.81% 5
2015
Q3
$127M Hold
1,542,247
2.82% 3
2015
Q2
$136M Hold
1,542,247
2.83% 2
2015
Q1
$136M Sell
1,542,247
-54,349
-3% -$4.82M 2.76% 3
2014
Q4
$133M Hold
1,596,596
2.65% 5
2014
Q3
$135M Hold
1,596,596
3.08% 6
2014
Q2
$130M Hold
1,596,596
2.88% 8
2014
Q1
$122M Hold
1,596,596
2.71% 9
2013
Q4
$115M Hold
1,596,596
2.6% 10
2013
Q3
$110M Sell
1,596,596
-77,451
-5% -$5.12M 2.54% 13
2013
Q2
$106M Buy
+1,674,047
New +$109M 2.38% 16

Other funds holding NVS

United States Steel & Carnegie Pension Fund's NVS Position: Q3 2017 in Review

United States Steel & Carnegie Pension Fund held its Novartis (NVS) position steady in Q3 2017 at 813,541 shares worth $62.6M. The position accounts for 2.86% of the portfolio, ranked #8.

United States Steel & Carnegie Pension Fund first reported a position in NVS in Q2 2013 and has held it in 18 quarters since. The position peaked at $136M in Q1 2015. 938 funds tracked by Wall St. Rank hold NVS as of Q3 2017.

  • United States Steel & Carnegie Pension Fund held 813,541 shares of Novartis worth $62.6M as of Q3 2017.
  • United States Steel & Carnegie Pension Fund left its Novartis share count unchanged in Q3 2017.
  • Novartis made up 2.86% of United States Steel & Carnegie Pension Fund's portfolio in Q3 2017, its #8 holding.
  • United States Steel & Carnegie Pension Fund first reported a position in Novartis in Q2 2013 and has held it in 18 quarters since.
  • United States Steel & Carnegie Pension Fund's Novartis position peaked at $136M in Q1 2015.
  • 938 funds tracked by Wall St. Rank held Novartis as of Q3 2017.

Based on United States Steel & Carnegie Pension Fund's 13F filing for Q3 2017, filed 9 Nov 2017.